Data / Form D filings / QUICKTAKE HEALTH CO
QUICKTAKE HEALTH CO: Form D filings
QUICKTAKE HEALTH CO, a biotechnology company in New Orleans, LA, filed 2 Form D notices with the SEC between 2022 and 2026. The latest, on August 6, 2026, reports $2.1 million sold of a $2.1 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1441 Canal Street Suite 324, New Orleans, LA, 70112
- Phone
- (504) 710-8564
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1929673
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | New notice | $2,070,000 | $2,070,000 | 5 | Mar 20, 2023 | sec.gov | |
| Dec 29, 2022 | New notice | $500,000 | $220,000 | $280,000 | 6 | Sep 30, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rand Ragusa | Executive Officer, Director | |
| John Biagas | Director | |
| Paige Clayton | Director | |
| Andrew Brett Murphy | Director | |
| Patrick Pendley | Director |
Other biotechnology companies in Louisiana that filed recently
- 28bio, Inc. $8.5 million · Oct 29, 2026
- Therapeutic Neuromodulation Systems LLC $1.7 million · Sep 21, 2026
Every Form D from the week of Aug 3, 2026 · All recent filings in Louisiana · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what QUICKTAKE HEALTH CO reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.